FY14 Phase II Awards

The Chemical and Biological Defense (CBD) SBIR Program received 25 Phase II proposals for the FY14 cycle. All of the Phase II proposals received a comprehensive technical evaluation in accordance with the evaluation criteria published in the solicitation, and were prioritized for award; 17 Phase II proposals were selected for award. Awards will be made based on successful negotiations with the small business in addition to availability of funds.

Topic Title Company
CBD13-110 Self-Healing Shape Memory Polymer Coatings for Chemical/Biological Protective Clothing Triton Systems, Inc.
CBD13-109 Microfiber-Based Closures with Hermetic Sealing for Chem-Bio Protective Garments nanoGriptech, Inc.
CBD13-109 Hermetic Seals for Chemical/Biological Protective Garments Creare Inc.
CBD13-108 Rapid Biodosimetry for accurate assessment of individual radiation exposure levels Active Spectrum, Inc.
CBD13-107 Microhydrogel Depot for Sustained Delivery of Prophylactic Bioscavenger Luna Innovations Incorporated
CBD13-107 Development of a long-acting, injectable controlled release butyrylcholinesterase formulation using predictive modeling Qrono Inc
CBD13-106 A Miniature Autoinjector for Multicomponent Drugs and Vaccines Creare Inc.
CBD13-106 ARCH Technology for a Simple, Resilient, and Cost-effective Auto-Injector AktiVax, Inc.
CBD13-105 Development of Low Cost Infrared Focal Plane Array for Passive Chemical Detection Using Colloidal Quantum Dots Brimrose Technology Corporation
CBD13-105 A Low-Cost, High-Performance Colloidal Quantum Dot LWIR FPA for Hyperspectral Imaging Sivananthan Laboratories, Inc.
CBD13-104 AOTF Based Spectro-Polarimetric Imaging System for Stand-off Chemical Brimrose Technology Corporation
CBD13-103 Advanced Real-time Surface Contamination Sensor DBC Technology Corp.
CBD13-102 Global Spatiotemporal Disease Surveillance System HOLOMIC LLC
CBD13-101 Responsive Sequestration Coating TDA Research, Inc.
CBD12-102 An Automated, High throughput resin-free device for large scale protein purification CFD Research Corporation
CBD12-101 Enhancing the Pharmacokinetic Profile of Protein-based Drugs Extend Biosciences Inc.
CBD11-105 Solid state deep UV laser for Raman detection of CB agents Arete Associates
Last Update: October 14, 2014